Lidocaine vaginal gel - Catalent
Alternative Names: 10% lidocaine gel - Juniper Pharmaceuticals; COL-1077Latest Information Update: 20 Jan 2022
At a glance
- Originator Columbia Laboratories
- Developer Columbia Laboratories; Juniper Pharmaceuticals
- Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Non-opioid analgesics; Small molecules
- Mechanism of Action Cell membrane permeability inhibitors; Opioid receptor agonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Pain
Highest Development Phases
- Discontinued Dysmenorrhoea; Pain